9780309044868: Biomedical Politics

Inhaltsangabe

Six case studies with commentary offer a look at the interplay of scientists, interest groups, US Congress, federal agencies, and the public in determining biomedical public policy and suggest rationalization. Annotation copyright Book News, Inc. Portland, Or.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorin bzw. den Autor

Kathi E. Hanna, Editor; Committee to Study Decision Making, Division of Health Sciences Policy

Von der hinteren Coverseite

Biomedical science is a double-edged sword. While providing advances in the treatment and quality of life for victims of disease, it also raises agonizing and thorny questions: Should scientists be allowed to pursue research on treatment of disease using fetal tissue from induced abortions? Should terminally ill patients be allowed to choose their own treatment, even if the safety and effectiveness of those treatments are unknown? Should American women be denied access to a nonsurgical abortifacient because some groups feel its use is immoral?We do have some important guidance, however, in the form of several recent decisions, arrived at through arduous give-and-take. In this book from the Institute of Medicine, six landmark cases offer insight into how we might confront future decisions more productively.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.